Sponsors (4)
The bill strengthens U.S. sanctions and enforcement tools to disrupt PRC‑linked illicit synthetic narcotics networks and protect national security and public health, but does so with broad definitions and banking restrictions that raise compliance costs, legal uncertainty, diplomatic risk, and potential disruption to legitimate cross‑border trade and remittances.
Financial institutions, law enforcement, and federal agencies can continue and expand sanctions and asset‑blocking authorities to disrupt PRC‑linked illicit synthetic narcotics supply chains, supporting investigations and pressuring bad actors economically.
Regulators and prosecutors (and Congress) get clearer statutory definitions of 'illicit synthetic narcotics' and related substances, improving the ability to identify, charge, and interdict drug supply‑chain actors and protect public health.
U.S. banks and customers gain stronger tools (account blocks and correspondent‑bank restrictions) to prevent foreign institutions from moving funds for designated illicit actors, strengthening the effectiveness of sanctions and reducing illicit finance risk.
U.S. banks, other financial institutions, businesses, and ultimately consumers and taxpayers face increased compliance costs, reporting burdens, and legal risk from broader sanctions, blocking and screening requirements, and new reporting obligations.
Broad and vague definitions (e.g., 'reckless disregard,' acts 'for or on behalf of,' subsidiaries/affiliates, and a 'should‑have‑known' mens rea) create legal uncertainty that could chill legitimate trade, expand liability for indirect conduct, and complicate compliance for immigrants, firms, and banks.
Designations of PRC entities and expanded sanctions risk diplomatic friction or economic retaliation from the PRC, which could harm U.S. exporters, workers, and broader U.S.–China economic ties.
Based on analysis of 5 sections of legislative text.
Codifies existing fentanyl-related sanctions and authorizes the President to use IEEPA to block property and sanction foreign persons tied to PRC-linked illicit synthetic narcotics, and lets Treasury restrict correspondent accounts for complicit foreign banks.
Official title: To authorize sanctions relating to the production and distribution of illicit synthetic narcotics by the People's Republic of China.
Introduced August 24, 2026 by Jake Auchincloss · Last progress August 24, 2026
Codifies existing Executive Order 14059 sanctions and creates a statutory authority to use IEEPA to sanction foreign persons tied to the international proliferation of illicit synthetic narcotics connected to the People’s Republic of China (including Hong Kong and Macau). The President may block property and transactions, impose civil and criminal penalties for violations, and waive measures for national security reasons. The bill also authorizes Treasury (with State consultation) to restrict or condition U.S. correspondent and payable-through accounts for foreign banks that knowingly facilitate transactions for sanctioned persons. Definitions, committee consultation rules, waiver procedures, and enforcement mechanisms are included, and most new sanction authorities become available 180 days after enactment.